Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. This was in early pandemic ...

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

The Japanese government discarded Covid-19 oral medicines believed to be worth around 240 billion yen (US$1.6 billion) in the ...

The Japanese government discarded Covid-19 oral medicines believed to be worth around 240 billion yen (RM6.85 billion) in the ...

Australia ‘undervalues’ the products of drug companies, Pfizer has told the Productivity Commission, echoing US lobbyists ...

Supporting cutting-edge research at colleges and universities — even, or especially, in its earliest stages, before anyone ...

New York City mayoral candidate Zohran Mamdani told business leaders that he would begin to discourage the use of the phrase ...

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $133.42, a high estimate of $155.00, and a low estimate of $110.00. A negative shift in sentiment is evident ...

Today’s the day: Gov. RON DESANTIS is expected to appoint state Sen. BLAISE INGOGLIA, a hard-charging former state GOP leader ...

Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...